ATLAS / Macro Radar / Reporting / LXEO

Lexeo Therapeutics, Inc. (LXEO) reporting calendar

Lexeo Therapeutics, Inc. files periodic reports with the SEC as LXEO on Nasdaq. Atlas tracks 11 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
17 Jul 2026 – 7 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
11

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open LXEO market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001193125-26-215678
10-K31 Dec 202530 Mar 202689 days0001193125-26-132085
10-Q30 Sep 20255 Nov 202536 days0001193125-25-265757
10-Q30 Jun 202514 Aug 202545 days0000950170-25-108427
10-Q31 Mar 202512 May 202542 days0000950170-25-068536
10-K31 Dec 202424 Mar 202583 days0000950170-25-043486
10-Q30 Sep 202413 Nov 202444 days0000950170-24-125943
10-Q30 Jun 202412 Aug 202443 days0000950170-24-095057
10-Q31 Mar 20249 May 202439 days0000950170-24-056247
10-K31 Dec 202311 Mar 202471 days0000950170-24-028941
10-Q30 Sep 202311 Dec 202372 days0000950170-23-069192

Source: SEC EDGAR company submissions for CIK 0001907108. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.